Fujifilm Photography News and Rumors

We have been following Fujifilm Avigan (Favipiravir) and COVID-19 involvement for a while ( 1, 2, 3, 4, 5, 6, 7, 8, 9, 10. 11, 12, 13) and trials keep coming up with positive results. It is now being reported that Fujifilm is sharing their “wonder drug” via the Japanese Government with 43 countries for approval in the treatments of COVID-19 via the United Nations Office for Project Services. This initial shipment should treat between 20 to 100 people per country.

Japanese Prime Minister Shinzo Abe wants favipiravir approved for Covid-19 in May, as Japan moves to fast-track approval for remdesivir as well, which the United States has backed. As of now, Remdesivir is gaining acceptance for the treatment of sever cases of COVID-19, but it is hoped that Fujifilm’s Avigan (Favipiravir) can be used to treat more mild cases. Read More »

Translated
Notification of application of public medical insurance to the new gene detection kit “SARS-CoV-2 RT-qPCR Detection kit” for coronavirus that greatly shortens PCR test time (Fujifilm Wako Pure Chemical)
FUJIFILM Wako Pure Chemical Industries, Ltd. (Head office: Chuo-ku, Osaka, President: Kazuo Shiraki) has announced that the research reagent “SARS-CoV-2 RT-qPCR

Detection kit” released on April 15 is a health insurance for the Ministry of Health, Labor and Welfare. In the “Regarding 2019-nCoV gene testing method for which evaluation results using clinical specimens were obtained” by the Department of Tuberculosis and Infectious Diseases Division and the National Institute of Infectious Diseases (May 1, 2020 edition), the positive concordance rate, The results were published with both negative and negative concordance rates of 100% and were covered by public medical insurance. * 1 So let me know.

PCR tests for the presence of new coronavirus infection include sample pretreatment, RNA extraction, and reverse transcription reaction that converts RNA into DNA. * 2 , Real-time PCR for real-time monitoring of target DNA amplification * 3 It is necessary to go through each step of, and it takes a long time to judge the result. Read More »

FUJIFILM Diosynth Biotechnologies teams with COVID-19 Therapeutics Accelerator to reserve manufacturing capacity and provide technical expertise to deliver future COVID-19 therapies
HILLERØD, Denmark, April 30, 2020 – FUJIFILM Diosynth Biotechnologies, a world leading biologics-Contract Development and Manufacturing Organization (CDMO), today announced that it will reserve manufacturing capacity for a future COVID-19 therapy for the COVID-19 Therapeutics Accelerator. The Therapeutics Accelerator is an initiative launched by the Bill & Melinda Gates Foundation, Wellcome, and Mastercard to speed-up the response to the global pandemic.

Currently, there are no established therapies for the treatment of COVID-19. To help address the global crisis, the Therapeutics Accelerator is working to accelerate drug development and will identify a promising COVID-19 therapeutic candidate based on efficacy and safety data demonstrated in clinical trials. Read More »